Thyroid cancers

Iodine-131 is used to treat thyroid cancer. It decays by beta emission and has a half-life of 8.1 days. 

Measured by a radioactivity calibration system before administering PO 4—10 mQ thyroid cancer 50—150 mQ... 

Half-lives span a very wide range (Table 17.5). Consider strontium-90, for which the half-life is 28 a. This nuclide is present in nuclear fallout, the fine dust that settles from clouds of airborne particles after the explosion of a nuclear bomb, and may also be present in the accidental release of radioactive materials into the air. Because it is chemically very similar to calcium, strontium may accompany that element through the environment and become incorporated into bones once there, it continues to emit radiation for many years. About 10 half-lives (for strontium-90, 280 a) must pass before the activity of a sample has fallen to 1/1000 of its initial value. Iodine-131, which was released in the accidental fire at the Chernobyl nuclear power plant, has a half-life of only 8.05 d, but it accumulates in the thyroid gland. Several cases of thyroid cancer have been linked to iodine-131 exposure from the accident. Plutonium-239 has a half-life of 24 ka (24000 years). Consequently, very long term storage facilities are required for plutonium waste, and land contaminated with plutonium cannot be inhabited again for thousands of years without expensive remediation efforts. 

The nuclear explosions that devastated Hiroshima and Nagasaki killed 100,000 to 200,000 people instantaneously. Probably an equal number died later, victims of the radiation released in those explosions. Millions of people were exposed to the radioactivity released by the accident at the Chernobyl nuclear power plant. The full health effects of that accident may never be known, but 31 people died of radiation sickness within a few weeks of the accident, and more than 2000 people have developed thyroid cancer through exposure to radioactive iodine released in the accident. Even low levels of radiation can cause health problems. For this reason, workers in facilities that use radioisotopes monitor their exposure to radiation continually, and they must be rotated to other duties if their total exposure exceeds prescribed levels. 

HORN-ROSS P L, HOGGATT K J, LEE M M (2002) Phytoestrogeus and thyroid cancer risk the San Francisco bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 11 43-9. 

An inverse correlation between thyroid cancer risk and phytoestrogens was recently proposed as a result of a multi-ethnic population-based case control study conducted in the San Francisco Bay Area (Hom-Ross et al., 2002). In this study, dietary habits and phytoestrogen consumption were assessed by a food-frequency questionnaire and by a nutrient database. The outcome of the study was that soy-based foods and alfalfa sprouts were associated with a reduction of thyroid cancer risk, whereas a Western diet did not influence cancer risk. No difference was observed between American and Asian women or between pre- and postmenopausal women. Furthermore, among the few compounds examined, the isoflavones genistein and daidzein and the lignan secoisolariciresinol were the phytoestrogens most frequently associated with risk reduction (Horn-Ross et al., 2002). 

Toxic adenoma Thyroid cancer Struma ovarii... 

In patients with thyroid cancer, the desired outcomes with LT4 therapy often are different from those in the hypothyroid patient. 

REE Codes for a growth factor receptor Thyroid cancer... 

Although the effects of chronic exposure of humans to low levels of POPs are difficult to predict, some biological effects have been described. For example, exposure of children to PCBs and PCDD/Fs may be linked to an elevated risk for infectious diseases. Exposure of pregnant women to PCDD/Fs may cause lower fertility in their male offspring. The adverse effects to human health of acute and chronic exposure of high concentrations of POPs, especially among industrial workers exposed to daily intakes of chemicals, are more evident. Elevated concentrations of DDE and TCDD have been associated with the development of cancers such as breast cancer, leukaemia and thyroid cancer. Dioxin exposure may also be associated with immunotoxicity, reproductive diseases and neurotoxicity. Extreme exposure to chlorinated compounds has resulted in death [101]. 

Gonsky R et al. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines use of a targeted differential RNA display method to select for mRNA subsets. Nucleic Acids Res 1997 25 3823-3831. 

TSH is approved for medical use as a diagnostic aid in the detection of thyroid cancer/thyroid remnants in post-thyroidectomy patients. Thyroid cancer is relatively rare, exhibiting highest... 

Gy Whole body Single brief exposure Linear dose relation to thyroid cancer, and pathology in adjacent parathyroid and salivary glands 16... 

After the nuclear explosion at Chernobyl in 1986, Anatoly and other professors and physicians created a foundation, For the Children of Chernobyl. Their goal was to send children abroad for the summers for a reprieve from radiation exposure which impairs their immune systems and has resulted in unprecedented levels of thyroid cancer in children and adults. The first host country to respond to their call for help was India. Before long, the foundation was sending 30,000 children every summer to host families and programs in many countries, including Germany, England, Japan, the U.S., Spain, Italy and France. 

Cranberry scare (1959, US) Use of aminotriazole, weed killer, thyroid cancer scare... 

Iodine-131 is useful in the treatment of thyroid cancer and has a t1/2 of 8 days. How long would it take to decay to 25% of its original amount ... 

If only multiples of half-lives are considered, the calculations are very straightforward. For example, 1-131 is used in the treatment of thyroid cancer and has a tu2 of eight days. How long would it take to decay to 25% of its original amount Looking at the chart, you see that 25% decay would occur at two half-lives or 16 days. However, since radioactive... 

Radiotherapy is a local treatment aiming to achieve local control or cure of locally confined tumours. It cannot treat metastases. Radiotherapy may be administered as external beam radiotherapy with X-rays or gamma rays, in sealed radioactive sources (e.g. prostate brachytherapy), or unsealed sources (e.g. orally administered radioiodine for thyroid cancer, intravenous strontium-89 for bone metastases). In external beam radiotherapy, the X-ray or gamma ray beams are targeted at the tumour to damage and kill the tumour cells. Inevitably, surrounding normal tissues are also affected resulting in the early and late side effects of radiotherapy. 

The lARC has determined that there is sufficient evidence for the carcinogenicity of amitrole to experimental animals and inadequate evidence for carcinogenicity to humans. It was noted that amitrole produces thyroid tumors in rodents by a nongenotoxic mechanism that involves interference with the functioning of the thyroid peroxidase, resulting in a reduction in circulating thyroid hormone concentration and an increase secretion of thyroid-stimulating hormone. Amitrole would not be expected to produce thyroid cancer in humans exposed to concentrations that do not alter thyroid hormone homeostasis. 

---